161 related articles for article (PubMed ID: 22574901)
1. Impact of an exercise program on acylcarnitines in obesity: a prospective controlled study.
Rodríguez-Gutiérrez R; Lavalle-González FJ; Martínez-Garza LE; Landeros-Olvera E; López-Alvarenga JC; Torres-Sepúlveda MR; González-González JG; Mancillas-Adame LG; Salazar-Gonzalez B; Villarreal-Pérez JZ
J Int Soc Sports Nutr; 2012 May; 9(1):22. PubMed ID: 22574901
[TBL] [Abstract][Full Text] [Related]
2. Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons.
Zhang J; Light AR; Hoppel CL; Campbell C; Chandler CJ; Burnett DJ; Souza EC; Casazza GA; Hughen RW; Keim NL; Newman JW; Hunter GR; Fernandez JR; Garvey WT; Harper ME; Fiehn O; Adams SH
Exp Physiol; 2017 Jan; 102(1):48-69. PubMed ID: 27730694
[TBL] [Abstract][Full Text] [Related]
3. Circulating long-chain acylcarnitine concentrations are not affected by exercise training in pregnant women with obesity.
Allman BR; Spray BJ; Lan RS; Andres A; Børsheim E
J Appl Physiol (1985); 2022 Feb; 132(2):470-476. PubMed ID: 34989648
[TBL] [Abstract][Full Text] [Related]
4. Anesthesia and bariatric surgery gut preparation alter plasma acylcarnitines reflective of mitochondrial fat and branched-chain amino acid oxidation.
Bhattacharyya S; Ali M; Smith WH; Minkler PE; Stoll MS; Hoppel CL; Adams SH
Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E690-E698. PubMed ID: 28830869
[TBL] [Abstract][Full Text] [Related]
5. The association between acylcarnitine and amino acids profile and metabolic syndrome and its components in Iranian adults: Data from STEPs 2016.
Taghizadeh H; Emamgholipour S; Hosseinkhani S; Arjmand B; Rezaei N; Dilmaghani-Marand A; Ghasemi E; Panahi N; Dehghanbanadaki H; Ghodssi-Ghassemabadi R; Najjar N; Asadi M; Khoshniat M; Larijani B; Razi F
Front Endocrinol (Lausanne); 2023; 14():1058952. PubMed ID: 36923214
[TBL] [Abstract][Full Text] [Related]
6. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women.
Adams SH; Hoppel CL; Lok KH; Zhao L; Wong SW; Minkler PE; Hwang DH; Newman JW; Garvey WT
J Nutr; 2009 Jun; 139(6):1073-81. PubMed ID: 19369366
[TBL] [Abstract][Full Text] [Related]
7. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
[TBL] [Abstract][Full Text] [Related]
8. Plasma and urine metabolic profiles are reflective of altered beta-oxidation in non-diabetic obese subjects and patients with type 2 diabetes mellitus.
Villarreal-Pérez JZ; Villarreal-Martínez JZ; Lavalle-González FJ; Torres-Sepúlveda Mdel R; Ruiz-Herrera C; Cerda-Flores RM; Castillo-García ER; Rodríguez-Sánchez IP; Martínez de Villarreal LE
Diabetol Metab Syndr; 2014; 6():129. PubMed ID: 25937838
[TBL] [Abstract][Full Text] [Related]
9. Effect of caloric restriction with and without exercise on metabolic intermediates in nonobese men and women.
Redman LM; Huffman KM; Landerman LR; Pieper CF; Bain JR; Muehlbauer MJ; Stevens RD; Wenner BR; Kraus VB; Newgard CB; Kraus WE; Ravussin E
J Clin Endocrinol Metab; 2011 Feb; 96(2):E312-21. PubMed ID: 21123443
[TBL] [Abstract][Full Text] [Related]
10. Increased acylcarnitine ratio indices in newborn screening for carnitine-acylcarnitine translocase deficiency shows increased sensitivity and reduced false-positivity.
Shi C; Ao Z; Liu B; Xiao X; Gu X; Yang Q; Hao H; Cai Y; Li S
Transl Pediatr; 2023 May; 12(5):871-881. PubMed ID: 37305732
[TBL] [Abstract][Full Text] [Related]
11. Profiling of Acylcarnitines in First Episode Psychosis before and after Antipsychotic Treatment.
Kriisa K; Leppik L; Balõtšev R; Ottas A; Soomets U; Koido K; Volke V; Innos J; Haring L; Vasar E; Zilmer M
J Proteome Res; 2017 Oct; 16(10):3558-3566. PubMed ID: 28786289
[TBL] [Abstract][Full Text] [Related]
12. Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders.
Shen JJ; Matern D; Millington DS; Hillman S; Feezor MD; Bennett MJ; Qumsiyeh M; Kahler SG; Chen YT; Van Hove JL
J Inherit Metab Dis; 2000 Feb; 23(1):27-44. PubMed ID: 10682306
[TBL] [Abstract][Full Text] [Related]
13. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
14. Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress.
Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Exil V; Duran M; Wijburg FA; Wanders RJ; Strauss AW
Eur J Clin Invest; 2004 Mar; 34(3):191-6. PubMed ID: 15025677
[TBL] [Abstract][Full Text] [Related]
15. Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy.
Truby LK; Regan JA; Giamberardino SN; Ilkayeva O; Bain J; Newgard CB; O'Connor CM; Felker GM; Kraus WE; McGarrah RW; Shah SH
Cardiovasc Diabetol; 2021 Aug; 20(1):161. PubMed ID: 34344360
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
[TBL] [Abstract][Full Text] [Related]
17. Postprandial changes in plasma acylcarnitine concentrations as markers of fatty acid flux in overweight and obesity.
Ramos-Roman MA; Sweetman L; Valdez MJ; Parks EJ
Metabolism; 2012 Feb; 61(2):202-12. PubMed ID: 21820684
[TBL] [Abstract][Full Text] [Related]
18. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
[TBL] [Abstract][Full Text] [Related]
19. Markers of branched-chain amino acid catabolism are not affected by exercise training in pregnant women with obesity.
Allman BR; Spray BJ; Mercer KE; Andres A; Børsheim E
J Appl Physiol (1985); 2021 Mar; 130(3):651-659. PubMed ID: 33444120
[TBL] [Abstract][Full Text] [Related]
20. Acylcarnitines: potential implications for skeletal muscle insulin resistance.
Aguer C; McCoin CS; Knotts TA; Thrush AB; Ono-Moore K; McPherson R; Dent R; Hwang DH; Adams SH; Harper ME
FASEB J; 2015 Jan; 29(1):336-45. PubMed ID: 25342132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
